Showing results (51-60 of 190) with videos related to

Sort By:
Pageof 19
Medical Oncology (Northwood, London, England)|January 1, 2010
Experience with sorafenib and the elderly patientJanice P Dutcher, Nizar Tannir, Joaquim Bellmunt, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 4, 2020
On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and ImmunotherapyJanice P Dutcher, Ronan Flippot, Jaleh Fallah, et al.
Leukemia & Lymphoma|December 29, 2004
Phase II study of all-trans retinoic acid in the accelerated phase or early blastic phase of chronic myeloid leukemia: a study of the Eastern Cooperative Oncology Group (E1993)Janice P Dutcher, Sandra Lee, Robert E Gallagher, et al.
Current Medical Research and Opinion|September 13, 2011
Single-agent rituximab in treatment-refractory or poor prognosis patients with chronic lymphocytic leukemiaPeter H Wiernik, Giridhar U Adiga
Medical Oncology (Northwood, London, England)|August 4, 2007
Adult T-cell leukemia/lymphoma presenting with bilateral hearing loss: a case reportSung Ho Lee, Peter H Wiernik
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 16, 2010
Novel management of pruritus in patients treated with IL-2 for metastatic renal cell carcinoma and malignant melanomaSung Ho Lee, Mahadi Baig, Valerie Rusciano, et al.
Medical Oncology (Northwood, London, England)|January 8, 2008
Serum globulins as marker of immune restoration after treatment with high-dose rituximab for chronic lymphocytic leukemiaDoru T Alexandrescu, Peter H Wiernik
Medical Oncology (Northwood, London, England)|August 4, 2007
The influence of parental age and gender on anticipation in familial B-cell malignanciesDoru T Alexandrescu, Peter H Wiernik
Seminars in Thrombosis and Hemostasis|October 9, 2012
Cocaine-levamisole thrombotic vasculopathyIrene A Dy, Peter H Wiernik
Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research|February 5, 2021
Long-term progression-free survival of patients with metastatic melanoma or renal cell carcinoma following high-dose interleukin-2Joseph I Clark, Brendan Curti, Elizabeth J Davis, et al.
Pageof 19